Spotlight On: Prostate Cancer Foundation

 

The Prostate Cancer Foundation (PCF) is a dynamic organization committed to funding cutting-edge prostate cancer research. Since 1993, the PCF has funded more than 1,600 programs at nearly 200 research facilities around the world. In 2012, the organization raised a record $47 million and expanded their research programs to China. Each year, the PCF partners […]

 

Learn More

 

 

From the Doc: Benefits of CyberKnife for Prostate Cancer Patients

 

Find out how stereotactic body radiation therapy (SBRT) with CyberKnife® can benefit prostate cancer patients. Below are some advantages from our medical director Dr. Douglas Rivera. What sets CyberKnife apart from other treatment options?CyberKnife offers patients a noninvasive treatment option that doesn’t impede on their lifestyle. CyberKnife can treat prostate cancer patients in five or […]

 

Learn More

 

 

Prostate Cancer Series: Understanding the Treatment Process

 

Austin CyberKnife is committed to helping patients understand their diagnosis and the treatment process. The video below provides an overview of how CyberKnife® treats prostate cancer and the benefits of using this advanced technology. This post is part of a series dedicated to addressing one of the most important health issues facing men today. Check […]

 

Learn More

 

 

Research Notes: High-dose Stereotactic Body Radiotherapy Effective, Quick for Localized Prostate Cancer

 

In a study presented at the 2012 annual meeting of the American Society of Radiation Oncology, researchers found that men with organ-confined prostate cancer can be treated successfully with stereotactic body radiation therapy. The five-year, multi-center study evaluated low-risk, intermediate-risk and high-risk patients for up to four years following treatment. At the five-year mark, the […]

 

Learn More

 

 

Prostate Cancer Staging

 

In a previous post, we discussed a basic overview of cancer staging. Prostate cancer is staged using the TNM system, established by the American Joint Committee on Cancer. The system uses five factors to stage prostate cancer: 1. The size of the tumor or “T” 2. The presence of cancer in nearby lymph nodes or […]

 

Learn More